Upgrade to SI Premium - Free Trial

Penumbra, Inc. (PEN)

324.66 +1.10 (0.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/4/26)

Latest Headlines

Penumbra wins FDA clearance for DVT treatment technology October 20, 2026 9:03 AM - StreetInsider Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT) October 20, 2026 9:02 AM - PR NewsWire Form 4 Penumbra Inc For: Oct 15 Filed by: Narayan Shruthi October 16, 2026 7:36 PM - SEC Filing New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism October 6, 2026 9:01 AM - PR NewsWire Form 4 Penumbra Inc For: Sep 15 Filed by: Narayan Shruthi September 17, 2026 7:32 PM - SEC Filing Form 4 Penumbra Inc For: Aug 17 Filed by: Narayan Shruthi August 19, 2026 7:23 PM - SEC Filing Form SCHEDULE 13G Penumbra Inc Filed by: BARCLAYS PLC August 13, 2026 6:48 PM - SEC Filing Penumbra, Inc. (PEN) Misses Q2 EPS by 28c July 30, 2026 5:00 PM - StreetInsider Form 10-Q Penumbra Inc For: Jun 30 July 30, 2026 4:45 PM - SEC Filing Form 8-K Penumbra Inc For: Jul 30 July 30, 2026 4:14 PM - SEC Filing Penumbra, Inc. Reports Second Quarter 2026 Financial Results July 30, 2026 4:05 PM - PR NewsWire Full Article List